Nogueira, Miguel
Puig, Luis http://orcid.org/0000-0001-6083-0952
Torres, Tiago http://orcid.org/0000-0003-0404-0870
Article History
First Online: 4 February 2020
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Miguel Nogueira has no conflicts of interest. Luis Puig has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Baxalta, Biogen, Boehringer Ingelheim, Celgene, Gebro, Janssen, LEO Pharma, Eli Lilly and Company, Merck-Serono, MSD, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi, and UCB. Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Janssen, Biocad, LEO Pharma, Eli Lilly, MSD, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme and Sandoz.